The Biogerontology Research Foundation (BGRF), a UK-based charity founded to support ageing research and address the challenges of a rapidly ageing population, hosted the inaugural 21st Century Medicine Forum on Monday, June 30th, with Aging Analytics, a company supporting financial decision-making in the biotechnology and regenerative medicine sector.
The speakers at the forum included:
Dmitry Kamenskiy, Senior Partner, Deep Knowledge Ventures, Hong Kong on 'Impact Investment to Advance Longevity Research'
Kate Elizarova, Actress, Model & Campaigner on 'Raising Cultural Awareness for Medical Advances & Longevity Research'
Eli Mohamad, Co-Founder, Organ Preservation Alliance, NASA Ames Research Center on 'An X-Prize for Organ Preservation'
Geoffrey Furlonger, CEO, Aging Analytics, United Kingdom on 'Longevity As a Challenge for Pension Funds & Life Insurance Companies'
Charles Groome, Consultant, Aging Analytics, United Kingdom on 'Novel Sources of Investment for Translational Research'
Henry Stanley, VP Strategy, BGRF on 'Charitable Contributions to Translational Longevity Research'
Alex Zhavoronkov, Director, BGRF on 'The Importance and Future of Longevity Research'
"We're incredibly excited to host the first of several meetings on cutting edge medical and longevity science," said Dr Alex Zhavoronkov, Director at the BGRF. "By bringing together class-leading researchers, pensions experts, financial heavyweights and science communicators at meetings like this, we hope to facilitate collaboration across disciplines and produce the next generation of projects that will take longevity science from the bench to the clinic."
Speaking at the event, model and actress Katya Elizarova commented: "Media spokespeople are often involved in charities aiming to beat Alzheimer's or cancer or another disease. Research into these topics is very important, obviously. But I think the most important thing is to support projects aimed at preventing ageing. And if researchers are clever enough to develop methods to do so, it's much more likely that they'll be able to treat these diseases with more success."
Videos of these talks are available. The next Forum event is anticipated to take place in Oxford, UK in October 2014.